| 000 | 01558 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517021438.0 | ||
| 264 | 0 | _c20151019 | |
| 008 | 201510s 0 0 jpn d | ||
| 022 | _a1349-7413 | ||
| 024 | 7 |
_a10.2177/jsci.37.468 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiyamoto, Katsuichi | |
| 245 | 0 | 0 |
_a[Topics of neuromyelitis optica]. _h[electronic resource] |
| 260 |
_bNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _c2014 |
||
| 300 |
_a468-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAquaporin 4 _ximmunology |
| 650 | 0 | 4 | _aAutoantibodies |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeuromyelitis Optica _xdiagnosis |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aPulse Therapy, Drug |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSex Factors |
| 773 | 0 |
_tNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _gvol. 37 _gno. 6 _gp. 468-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2177/jsci.37.468 _zAvailable from publisher's website |
| 999 |
_c24685785 _d24685785 |
||